Cannabis Global Inc (CBGL) announces the production of super premium concentrates at Lynwood facility

Cannabis stocks have shown some bright signals so far in 2022, most particularly in February, when the Secure and Fair Enforcement (SAFE) Banking Act passed the US House of Representatives (for the sixth time). There is new hope that the bill will finally make it through the Senate this time around.

If SAFE passes, it will be an enormous step toward fully legitimizing the cannabis industry on a Federal level and helping to push it further into mainstream US consumer daily life.

Rep. Ed Perlmutter (D-CO) has been the main force pushing SAFE through DC channels for the past few years. His latest attempt will work to enfold the bill into a large-scale manufacturing and innovation bill with language related to the cannabis industry attached.

What’s the main hurdle in the Senate? It’s actually that Senate leaders have prioritized a broader path to full federal legalization rather than the SAFE act, which leaders see as an incremental step that could undermine pressure to fully legalize.

Either way, there’s a long-term legislative tailwind for the cannabis industry, and for stocks tied to the space.

Given their depleted valuations after years of consolidation, 2022 could be coming into focus as a pivotal investment opportunity for market participants seeking exposure to the space. With that in mind, we take a look below at some of the most interesting names in the cannabis space.

GrowGeneration Corp. (NASDAQ:GRWG) engages in the retail of hydroponic and organic specialty gardening products. The comapny offers lighting fixtures, nutrients, seeds and growing media systems, trays, fans, filters, humidifiers and dehumidifiers, timers, instruments, water pumps, irrigation supplies, and hand tools. GrowGeneration Corp. (NASDAQ:GRWG) recently announced the acquisition of Horticultural Rep Group (HRG).

“With this acquisition, GrowGen is strengthening its global product supply chain and adding significant distribution of its growing list of private label products,” said Michael Salaman, President and co-founder of GrowGen. “Keith Harrington is one of the most respected executives and one of the early innovators of the U.S. modern horticultural market. We are excited that he will contribute his multi-decade expertise to the GrowGen team.”

Even in light of this news, GRWG hasn’t really done much of anything over the past week, with shares logging no net movement over that period. 

GrowGeneration Corp. (Nasdaq:GRWG) managed to rope in revenues totaling $116M in overall sales during the company’s most recently reported quarterly financial data — a figure that represents a rate of top line growth of 110.9%, as compared to year-ago data in comparable terms. In addition, the company has a strong balance sheet, with cash levels exceeding current liabilities ($93M against $72.5M).

Cannabis Global Inc. (OTC US:CBGL) bills itself as an emerging force in the cannabis marketplace with a growing product and proprietary intellectual property portfolio. 

The company produces and markets the Comply Bag, an innovative solution for cannabis storage, transport, and tracking. It also has an interesting subsidiary, Natural Plant Extract (NPE), licensed in Southern California as a cannabis manufacturer and distributor. NPE licenses its tech to partners for the production of edibles for the cannabis marketplace. CBGL has also filed three non-provisional and multiple provisional patents for cannabis infusion and nanoparticle technologies and continues an active research & development program.

Cannabis Global Inc. (OTC US:CBGL) most recently put out very interesting news related to a key enhancement to its cannabis manufacturing capabilities at NPE. The Company’s new production unit, named “213 Solventless Labs”, will specialize in producing solventless cannabis products like hash and rosin as well as solventless vape cartridges, and cannabis edibles. Operations have already begun with recent equipment installations.

“It is with great pride that we announce the production of super premium concentrates at our Lynwood facility,” CEO Arman Tabatabaei comments, “The art and science elements combined within this process allow us to produce some truly extraordinary products for the consumer cannabis markets.”

According to the company’s release, CBGL’s solventless extraction methods use water, ice and heat to extract the desirable components from cannabis plants. This process doesn’t produce any byproducts or harmful chemicals found in other types of extracting solvents like butane, which can alter taste profile and affect the end-user’s experience with the product.

Cannabis Global Inc. (OTC US:CBGL) shares have been sliding and could now be extremely cheap relative to peers given that the company does have commercial-stage operations and has put together a very compelling IP portfolio. Its new 213 Solventless Labs strategy could be the key to sparking a tipping point where market sentiment is concerned, especially if we start to see investment dollars flowing back into cannabis plays early this year as federal legislative momentum picks up.

Tilray Brands Inc. (Nasdaq:TLRY) bills itself as a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. 

The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad-spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. 

Tilray Brands Inc. (Nasdaq:TLRY) recently announced that its medical cannabis division, Tilray Medical, has completed its first sale of medical cannabis in Malta. Tilray’s EU-GMP medical cannabis products are now available in pharmacies across Malta, providing patients with safe and reliable access to high-quality medical cannabis.

Denise Faltischek, Tilray’s Chief Strategy Officer and Head of International Business, said, “As demand for cannabis continues to grow across Europe, we’re incredibly proud to partner with established and reliable distribution partners to supply new markets with high-quality medical cannabis which patients can rely on.”

We’ve witnessed flat action in the stock over the past month. It continues to trade under its 50-day moving average, but off its lows from January in the key $5/share area. Volume in TLRY has been steady.

Tilray Brands Inc. (Nasdaq:TLRY) currently trades at a market cap of $2.75 billion, with a significant war chest ($331.8M) of cash on the books, which compares with about $314.9M in total current liabilities. TLRY is pulling in trailing 12-month revenues of $431.1M. In addition, the company is seeing major top-line growth, with y/y quarterly revenues growing at 207.8%.

Other key stocks in the cannabis marketplace include Trulieve Cannabis Corp. (OTC US:TCNNF), Innovative Industrial Properties Inc. (NYSE:IIPR), Sundial Growers Inc. (Nasdaq:SNDL), Village Farms International Inc. (Nasdaq:VFF), and AdvisorShares Pure US Cannabis ETF (NYSEArca:MSOS).


Disclaimer: This is a paid advertisement. WallStreetPR is simply distributing content provided to us by EDM Media LLC and is not responsible for the production of this content. WallStreetPR is not operated by a licensed broker, a dealer, or a registered investment adviser. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. Our reports/releases are commercial advertisements and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The information made available to us by EDM Media LLC is not intended to be, nor does it constitute investment advice or recommendations. The contributors may buy and sell securities before and after any particular article, report, and publication. In no event shall WALLSTREETPR be liable to any member, guest, or third party for any damages of any kind arising out of the use of any content or other material published or made available by WALLSTREETPR ., including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information in this video, article, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. strongly urges you to conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. For some content,, its authors, contributors, or its agents, may be compensated for preparing research, video graphics, and editorial content. As part of that content, readers, subscribers, and website viewers are expected to read the full disclaimers and financial disclosures statement that can be found on our website by visiting has been compensated $1500 for advertisement services on CBGL by a 3rd party EDM Media LLC. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward-looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements in this action may be identified through the use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quotes; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled.

Media Contact
Company Name: WallStreetPR
Contact Person: Ash K
Email: [email protected]
Phone: 2019725655
Country: United States